PMID- 20686702 OWN - NLM STAT- MEDLINE DCOM- 20101028 LR - 20220410 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 5 IP - 7 DP - 2010 Jul 29 TI - The prepared tau exon-specific antibodies revealed distinct profiles of tau in CSF of the patients with Creutzfeldt-Jakob disease. PG - e11886 LID - 10.1371/journal.pone.0011886 [doi] LID - e11886 AB - BACKGROUND: The diagnostic value of CSF tau for Creutzfeldt-Jakob disease (CJD) has been widely evaluated, showing a markedly disease-relative manner. However, the profiles of tau isoforms in CSF of CJD patients remain unknown. Here, we prepared the exon-specific antibodies against the peptides encoded by exon-2, exon-3 and exon-10 of human tau protein and evaluated the reactive profiles of tau in CSF samples from the patients with probable CJD. METHODOLOGY/PRINCIPAL FINDINGS: Sequences encoding exon-2, exon-3 and exon-10 of human tau protein were cloned into a prokaryotic expression vector pGEX-2T. Using recombinant fusion proteins GST-E2, GST-E3 and GST-E10, three tau exon-specific antibodies were elicited. Reliable specificities of the prepared antibodies were obtained after a serial of purification processes, not only in recognizing the tau peptides encoded by exon-2, -3 and -10, but also in distinguishing six recombinant tau isoforms by Western blot and ELISA. Three predominant tau-specific bands were observed in CSF samples with the exon-specific and the commercial tau antibodies, respectively, showing different reactive profiles between the groups of probable CJD and non-CJD. A 65 KD band was detected only in the CSF samples from probable CJD patients, especially with the antibodies against exon-2 (Anti-tE2) and exon-10 (Anit-tE10). The appearances of 65 KD band in CSF correlated well with positive 14-3-3 in CSF and typical abnormality in EEG. Such band was not observed in the CSF samples of six tested genetic CJD patients. CONCLUSIONS/SIGNIFICANCE: Three exon-specific polyclonal antibodies were successfully prepared. Based on these antibodies, different CSF tau profiles in Western blots were observed between the groups of probable CJD and non-CJD. A disease-specific tau band emerged in the CSF samples from probable sporadic CJD, which may supply a new biomarker for screening sporadic CJD. FAU - Chen, Cao AU - Chen C AD - State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China. FAU - Shi, Qi AU - Shi Q FAU - Zhang, Bao-Yun AU - Zhang BY FAU - Wang, Gui-Rong AU - Wang GR FAU - Zhou, Wei AU - Zhou W FAU - Gao, Chen AU - Gao C FAU - Tian, Chan AU - Tian C FAU - Mei, Guo-Yong AU - Mei GY FAU - Han, Yan-Ling AU - Han YL FAU - Han, Jun AU - Han J FAU - Dong, Xiao-Ping AU - Dong XP LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20100729 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (14-3-3 Proteins) RN - 0 (Antibodies) RN - 0 (Recombinant Fusion Proteins) RN - 0 (tau Proteins) SB - IM MH - 14-3-3 Proteins/cerebrospinal fluid/immunology MH - Adult MH - Aged MH - Aged, 80 and over MH - Antibodies/*immunology MH - Antibody Specificity MH - Blotting, Western MH - Creutzfeldt-Jakob Syndrome/*metabolism MH - Enzyme-Linked Immunosorbent Assay MH - Exons/*genetics MH - Female MH - Humans MH - Male MH - Middle Aged MH - Recombinant Fusion Proteins/genetics/immunology/metabolism MH - tau Proteins/*cerebrospinal fluid/*immunology PMC - PMC2912377 COIS- Competing Interests: The authors have declared that no competing interests exist. EDAT- 2010/08/06 06:00 MHDA- 2010/10/29 06:00 PMCR- 2010/07/29 CRDT- 2010/08/06 06:00 PHST- 2010/04/20 00:00 [received] PHST- 2010/07/07 00:00 [accepted] PHST- 2010/08/06 06:00 [entrez] PHST- 2010/08/06 06:00 [pubmed] PHST- 2010/10/29 06:00 [medline] PHST- 2010/07/29 00:00 [pmc-release] AID - 10-PONE-RA-18132R2 [pii] AID - 10.1371/journal.pone.0011886 [doi] PST - epublish SO - PLoS One. 2010 Jul 29;5(7):e11886. doi: 10.1371/journal.pone.0011886.